Comparison of the Swedish and Finnish Centers in the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Background and objective: The European Randomized Study of Screening for Prostate Cancer showed 20% reduction in prostate cancer (PC) mortality after 16 year follow-up of prostate-specific antigen (PSA) based screening, but effects varied: 9% in Finland (FinRSPC) vs 37% in Sweden (Göteborg-1) in scr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marianne Månsson, Kirsi Talala, Anssi Auvinen, Jonas Hugosson
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-06-01
Colecção:	European Urology Open Science
Assuntos:	Cancer-specific mortality Contamination Prostate cancer Prostate-specific antigen Screening
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666168326004933
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!